Saving the Lives of People with Blood Cancer
by
The annual EBMT conference was held in Frankfurt this year, and brought together the world’s leading stem cell transplantation clinicians and scientists to share their latest findings. Members of our Patient Services team attended the conference, alongside our clinical nurse specialists and our recently appointed clinical psychologists. These are their highlights. All aspects of stem…
by
After new findings from Anthony Nolan’s Patient/Donor project have been published, Jonathan from our Patient Services team looks at how new technology is helping us understand what the best possible match now looks like, and what this means for future patients. At Anthony Nolan, we use our stem cell register of over 700,000 people to…
by
Jonathan in our patient services team discusses emerging treatments for cancer, using cell therapy and new ‘super cells’. When developing a new cancer treatment, one of the most important things to consider is how well it can be tolerated by patients. Often the amount of drug that can be given is limited by the side…
by
Jonathan in the Patient Services team discusses recent research into the use of cell therapies to treat Graft versus Host Disease (GvHD), which is a common side effect of stem cell transplant. He also looks at the implications this may have for patients whose symptoms have not responded to standard treatments. Graft vs Host…
by
A healthy gut We have known for a long time that our digestive system is home to billions of tiny microbes that help us digest our food properly. We are even encouraged to look after them by drinking “pro-biotic” products that we are told will aid our digestion. But recent research has shown that bacteria…
by
An exciting new therapy for people with blood cancer has been approved for use in the USA. It involves collecting a patient’s own immune cells, modifying them to target cancer cells more efficiently and then injecting them back into the patient. The treatment, called Kymriah and produced by drug company Novartis, is one of many…
